Olpasiran
amgen
[]
near-complete elimination of blood lipoprotein(a) with an sirna-based targeted therapy administered once every 3 months in patients with established ascvd. this is very exciting #aha22 
Professor, Department of Medicine @universitelaval
Cardiometabolic diseases prevention & genetics researcher @IUCPQ
Chroniqueur @rcmoteur
Co-président @sqlnm_